Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Oncolytic viruses and cancer therapy.

Literature DB >> 11325607

Oncolytic viruses and cancer therapy.

K L Norman¹, F Farassati, P W Lee.

Abstract

Entities: Disease

Mesh：

Year: 2001 PMID： 11325607 DOI： 10.1016/s1359-6101(00)00024-1

Source DB: PubMed Journal: Cytokine Growth Factor Rev ISSN： 1359-6101 Impact factor: 7.638

Keyword Cloud
Cited

× No keyword cloud information.

10 in total

1. Oncolytic virotherapy synergism with signaling inhibitors: Rapamycin increases myxoma virus tropism for human tumor cells.

Authors: Marianne M Stanford; John W Barrett; Steven H Nazarian; Steven Werden; Grant McFadden
Journal: J Virol Date: 2006-11-15 Impact factor: 5.103

2. Overactivation of Ras signaling pathway in CD133+ MPNST cells.

Authors: Emma Borrego-Diaz; Kaoru Terai; Kristina Lialyte; Amanda L Wise; Tuba Esfandyari; Fariba Behbod; Victor F Mautner; Melanie Spyra; Sarah Taylor; Luis F Parada; Meena Upadhyaya; Faris Farassati
Journal: J Neurooncol Date: 2012-04-08 Impact factor: 4.130

3. Myxoma virus is a novel oncolytic virus with significant antitumor activity against experimental human gliomas.

Authors: Xueqing Lun; Wenqing Yang; Tommy Alain; Zhong-Qiao Shi; Huong Muzik; John W Barrett; Grant McFadden; John Bell; Mark G Hamilton; Donna L Senger; Peter A Forsyth
Journal: Cancer Res Date: 2005-11-01 Impact factor: 12.701

4. Ras signaling influences permissiveness of malignant peripheral nerve sheath tumor cells to oncolytic herpes.

Authors: Faris Farassati; Weihong Pan; Farnaz Yamoutpour; Susann Henke; Mark Piedra; Silke Frahm; Said Al-Tawil; Wells I Mangrum; Luis F Parada; Samuel D Rabkin; Robert L Martuza; Andreas Kurtz
Journal: Am J Pathol Date: 2008-11-06 Impact factor: 4.307

Oncolytic viruses and cancer therapy.

1. Oncolytic virotherapy synergism with signaling inhibitors: Rapamycin increases myxoma virus tropism for human tumor cells.

2. Overactivation of Ras signaling pathway in CD133+ MPNST cells.

3. Myxoma virus is a novel oncolytic virus with significant antitumor activity against experimental human gliomas.

4. Ras signaling influences permissiveness of malignant peripheral nerve sheath tumor cells to oncolytic herpes.

5. An overview on the development of newcastle disease virus as an anti-cancer therapy.

6. Apoptosis-inducing effect of myxoma virus on human neuroglioma cell lines.

Review 7. Oncolytic virotherapy for urological cancers.

Review 8. Oncolytic viruses & their specific targeting to tumour cells.

Review 9. Oncolytic viruses in head and neck cancer: a new ray of hope in the management protocol.

10. hTERT extends the life of human fibroblasts without compromising type I interferon signaling.